News & Updates
Filter by Specialty:
Increasing trend in DOAC-related intracerebral haemorrhage: How to improve outcomes?
New local findings presented at HKMF 2024 show an increasing trend in intracerebral haemorrhage (ICH) among patients on direct oral anticoagulants (DOACs) between 2013 and 2022. Early initiation of reversal agents may improve outcomes in select cases with DOAC-related ICH.
Increasing trend in DOAC-related intracerebral haemorrhage: How to improve outcomes?
30 May 2024
Earlier menopause, higher CV risk may lead to cognitive decline
Earlier menopause (occurring before age 49) coupled with higher risk of cardiovascular disease (CVD) is associated with an increased risk of cognitive problems later in life, a study suggests.
Earlier menopause, higher CV risk may lead to cognitive decline
28 May 2024
More evidence supports enzalutamide’s link with poorer mood and cognitive outcomes in mCRPC
Patients with metastatic castration-resistant prostate cancer (mCRPC) treated with enzalutamide reported more fatigue, depression and deterioration in perceived cognitive ability, and slower reaction time than those receiving abiraterone acetate, according to results of the ACE study.